Education
About Us
Working with TipRanks
Follow Us
Qyuns Therapeutics Co., Ltd. Class H (HK:2509)
:2509
RESEARCH TOOLSreports
Summary of all the Indicators
Overall Consensus
Strong Buy
15Bullish
6Neutral
1Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Qyuns Therapeutics Co., Ltd. Class H’s (2509) Moving Averages Convergence Divergence (MACD) indicator is 0.78, suggesting Qyuns Therapeutics Co., Ltd. Class H is a Buy.
Qyuns Therapeutics Co., Ltd. Class H’s (2509) 20-Day exponential moving average is 14.65, while Qyuns Therapeutics Co., Ltd. Class H’s (2509) share price is HK$15.26, making it a Buy.
Qyuns Therapeutics Co., Ltd. Class H’s (2509) 50-Day exponential moving average is 13.04, while Qyuns Therapeutics Co., Ltd. Class H’s (2509) share price is HK$15.26, making it a Buy.
Qyuns Therapeutics Co., Ltd. Class H (2509) Pivot Points
Classic
12.74
13.38
14.32
14.96
15.90
16.54
17.48
Fibonacci
13.38
13.98
14.36
14.96
15.56
15.94
16.54
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Qyuns Therapeutics Co., Ltd. Class H (2509) Moving Averages
MA5
15.21Buy
15.23Buy
MA10
15.23Buy
15.14Buy
MA20
15.08Buy
14.65Buy
MA50
12.76Buy
13.04Buy
MA100
10.47Buy
12.09Buy
MA200
12.06Buy
13.85Buy
Qyuns Therapeutics Co., Ltd. Class H’s (2509) 10-Day exponential moving average is 15.14, while Qyuns Therapeutics Co., Ltd. Class H’s (2509) share price is HK$15.26, making it a Buy.
Qyuns Therapeutics Co., Ltd. Class H’s (2509) 100-Day exponential moving average is 12.09, while Qyuns Therapeutics Co., Ltd. Class H’s (2509) share price is HK$15.26, making it a Buy.
Qyuns Therapeutics Co., Ltd. Class H’s (2509) stock price is HK$15.26 and Qyuns Therapeutics Co., Ltd. Class H’s (2509) 50-day simple moving average is 12.76, creating a Buy signal.
Qyuns Therapeutics Co., Ltd. Class H’s (2509) stock price is HK$15.26 and Qyuns Therapeutics Co., Ltd. Class H’s (2509) 100-day simple moving average is 10.47, creating a Buy signal.
Qyuns Therapeutics Co., Ltd. Class H’s (2509) stock price is HK$15.26 and Qyuns Therapeutics Co., Ltd. Class H’s (2509) 200-day simple moving average is 12.06, creating a Buy signal.
Qyuns Therapeutics Co., Ltd. Class H (2509) Technical Indicators
RSI (14)
61.51
Neutral
STOCH (9,6)
78.01
Neutral
STOCHRSI (14)
41.26
Neutral
MACD (12,26)
0.78
Buy
ADX (14)
36.61
Neutral
Williams %R
-63.22
Buy
CCI (14)
42.89
Neutral
ATR (14)
0.86
-
Ultimate Oscillator
67.95
Neutral
ROC
-2.67
Sell
Qyuns Therapeutics Co., Ltd. Class H’s (2509) Relative Strength Index (RSI) is 61.51, creating a Neutral signal.
Qyuns Therapeutics Co., Ltd. Class H’s (2509) Trend Strength Indicator (ADX) is 36.61, creating a Neutral signal.
Qyuns Therapeutics Co., Ltd. Class H’s (2509) Commodity Channel Index (CCI) is 42.89, creating a Neutral signal.
Qyuns Therapeutics Co., Ltd. Class H’s (2509) Price Rate of Change (ROC) is -2.67, creating a Sell signal.
FAQ
Is 2509 a Buy, Hold, or Sell?
Based on 2509’s technical indicators, 2509 is a Strong Buy.
What is 2509’s RSI (14)?
2509’s RSI (14) is 61.51, which suggests 2509 is a Neutral.
What is 2509’s MACD?
2509’s MACD is 0.78, which suggests 2509 is a Buy.
What is 2509’s 5-day moving average?
2509’s 5-day moving average is 15.21, which suggests 2509 is a Buy.
What is 2509’s 20-day moving average?
2509 20-day moving average is 15.08, which suggests 2509 is a Buy.
What is 2509’s 50-day moving average?
2509’s 50-day moving average is 12.76, which suggests 2509 is a Buy.
What is 2509’s 200-day moving average?
2509’s 200-day moving average is 12.06, which suggests 2509 is a Buy.
What is 2509’s Williams % R (14)?
2509’s Williams % R (14) is -63.22, which suggests 2509 is a Buy.
What is 2509’s CCI (14)?
2509’s CCI (14) is 42.89, which suggests 2509 is a Neutral.
What is the share price of Qyuns Therapeutics Co., Ltd. Class H?